5//SEC Filing
Kiaie Namvar 5
Accession 0001213900-21-008961
CIK 0001726711other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:05 PM ET
Size
12.9 KB
Accession
0001213900-21-008961
Insider Transaction Report
Form 5
Kiaie Namvar
Director
Transactions
- Purchase
Common Stock
2020-07-02+1,111→ 2,222 total - Exercise of In-Money
Common Stock
2020-07-22$11.25/sh+1,111$12,499→ 2,222 total - Purchase
Series A Warrant
2020-07-02+1,111→ 1,111 totalExercise: $4.50From: 2020-07-02Exp: 2025-07-02→ Common Stock (1,111 underlying) - Purchase
Series B Warrant
2020-07-02+1,111→ 0 totalExercise: $11.25From: 2020-07-02Exp: 2025-07-02→ Common Stock (1,111 underlying) - Exercise of In-Money
Series B Warrant
2020-07-22$11.25/sh−1,111$12,499→ 0 totalExercise: $0.00From: 2020-07-02Exp: 2025-07-02→ Common Stock (1,111 underlying)
Footnotes (1)
- [F1]The reported securities are included within 1,111 Units purchased by the reporting person for $9.00 per Unit. Each Unit consists of (a) one share of common stock, (b) one Series A Warrant to purchase one share of common stock, and (c) one Series B Warrant to purchase one share of common stock.
Documents
Issuer
Aditx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001817639
Filing Metadata
- Form type
- 5
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:05 PM ET
- Size
- 12.9 KB